menu
    • menu

    Company profile for Edenbridge Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Edenbridge Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing, and marketing prescription pharmaceutical products. Our goal is to create a broad portfolio of limited source branded and generic pharmaceutical products that will provide high-quality, affordable, and accessible alternatives in the healthcare market. Our approach is to work with best-in-class and like-minded industry partners ...
    Edenbridge Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing, and marketing prescription pharmaceutical products. Our goal is to create a broad portfolio of limited source branded and generic pharmaceutical products that will provide high-quality, affordable, and accessible alternatives in the healthcare market. Our approach is to work with best-in-class and like-minded industry partners to deliver our products to physicians and patients everywhere. Founded in 2008, we launched our first product in February 2010 and have sold our commercial products through every major channel of the U.S. prescription

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Edenbridge PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    169 Lackawanna Avenue, Suite 110 Parsippany, NJ 07054
    Telephone
    Telephone
    201-292-1292
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.edenbridgepharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PANTHERx®Rare Selected by Edenbridge as Specialty Pharmacy for Yargesa
    PANTHERx®Rare Selected by Edenbridge as Specialty Pharmacy for Yargesa

    01 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pantherxrare-selected-by-edenbridge-pharmaceuticals-as-specialty-pharmacy-for-yargesa-miglustat-100-mg-capsules-302104863.html

    PR NEWSWIRE
    01 Apr 2024
    Share Share
    Edenbridge Pharmaceuticals Names Douglas S. Boothe as CEO
    Edenbridge Pharmaceuticals Names Douglas S. Boothe as CEO

    20 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231220243841/en

    BUSINESSWIRE
    20 Dec 2023
    Share Share
    Enforcement Report - Week of November 8, 2023
    Enforcement Report - Week of November 8, 2023

    08 Nov 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-8-2023-82126.pdf

    FDA
    08 Nov 2023
    Share Share
    Edenbridge Pharma's Generic Doxepin Hydrochloride Receives Approval in the U.S.
    Edenbridge Pharma's Generic Doxepin Hydrochloride Receives Approval in the U.S.

    19 Apr 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213796

    FDA
    19 Apr 2022
    Share Share
    Edenbridge Pharmaceuticals Announces the Launch of DARTISLA ODT
    Edenbridge Pharmaceuticals Announces the Launch of DARTISLA ODT

    28 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220228005675/en

    BUSINESSWIRE
    28 Feb 2022
    Share Share
    FDA Approves Edenbridge's DARTISLA ODT Orally Disintegrating Tablets
    FDA Approves Edenbridge's DARTISLA ODT Orally Disintegrating Tablets

    17 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211217005400/en

    BUSINESSWIRE
    17 Dec 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search